Literature DB >> 3726881

Species differences in the disposition of inhaled butadiene.

J A Bond, A R Dahl, R F Henderson, J S Dutcher, J L Mauderly, L S Birnbaum.   

Abstract

Recent chronic inhalation carcinogenicity studies of butadiene indicated that B6C3F1 mice are more sensitive to the tumorigenic effects of inhaled butadiene than are Sprague-Dawley rats. Tumors in mice included lymphomas, hemangiosarcomas, alveolar/bronchiolar adenomas and carcinomas, and hepatocellular adenomas and carcinomas whereas in rats tumors included mammary tumors, thyroid follicular cell adenomas, uterine tumors, and exocrine pancreatic adenomas. The purpose of this investigation was to determine if there were differences in the uptake and disposition of inhaled butadiene between rats and mice and if these differences were consistent with the differences in the species susceptibility to inhaled butadiene. Male Sprague-Dawley rats and B6C3F1 mice were exposed nose only to concentrations in the range of 0.14 to 13,000 micrograms [14C]butadiene/liter air (0.08 to 7100 ppm; 25 degrees C, 620 torr) for 6 hr. Blood samples were taken during exposure and urine, feces, and expired air were collected for up to 65 hr after exposure. In both rats and mice there was a significant (p less than 0.001) concentration-related decrease in the percentage of butadiene retained at the cessation of a 6-hr exposure with increasing butadiene exposure concentration, suggesting saturable metabolism of this chemical. At all concentrations of butadiene tested, mice retained about 4 to 7 times the amount (mumol/kg body wt) of butadiene and metabolites than did rats. In both species and at all butadiene concentrations tested, urine and exhaled air were the major routes of excretion of 14C, together accounting for 75 to 85% of the total 14C eliminated. In mice, for all concentrations tested, elimination of 14C in urine, feces, and exhaled air increased with increasing butadiene exposure concentration, although the increase was not proportional to exposure concentration. However, exposure of rats to 13,000 micrograms butadiene/liter air resulted in a leveling off in the amount of 14C that was eliminated in urine and a concomitant increase in exhalation of 14CO2. Analysis of blood samples taken during exposure indicated that the blood of mice contained 2 to 5 times the concentration of 1,2-epoxy-3-butene than did the blood of rats. The data from this study indicate that species differences exist in the amount retained and metabolism of inhaled butadiene.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3726881     DOI: 10.1016/0041-008x(86)90268-1

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  14 in total

1.  Enzyme specific kinetics of 1,2-epoxybutene-3 in microsomes and cytosol from livers of mouse, rat, and man.

Authors:  P E Kreuzer; W Kessler; H F Welter; C Baur; J G Filser
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation.

Authors:  G Johanson; J G Filser
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

3.  Evaluation of DNA damage by alkaline elution technique after inhalation exposure of rats and mice to 1,3-butadiene.

Authors:  R R Vangala; R J Laib; H M Bolt
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

4.  Inhalation pharmacokinetics of 1,2-epoxybutene-3 reveal species differences between rats and mice sensitive to butadiene-induced carcinogenesis.

Authors:  R Kreiling; R J Laib; J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

Review 5.  Cancer risk assessment of 1,3-butadiene.

Authors:  I L Cote; S P Bayard
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

6.  Inhalation toxicology and carcinogenicity of 1,3-butadiene in B6C3F1 mice following 65 weeks of exposure.

Authors:  R L Melnick; J E Huff; J H Roycroft; B J Chou; R A Miller
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

Review 7.  Future directions--toxicology studies of 1,3-butadiene and isoprene.

Authors:  M G Bird
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

8.  Inhalation pharmacokinetics of 1,3-butadiene and 1,2-epoxybutene-3 in rats and mice.

Authors:  R J Laib; J G Filser; R Kreiling; R R Vangala; H M Bolt
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

9.  1,3-Butadiene: linking metabolism, dosimetry, and mutation induction.

Authors:  J A Bond; G A Csanady; M L Gargas; F P Guengerich; T Leavens; M A Medinsky; L Recio
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

Review 10.  A brief survey of butadiene health effects: a role for metabolic differences.

Authors:  L S Birnbaum
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.